Related Experiment Video
Updated: Jun 6, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature
Murali Subramanian1, R Manjunath, Nalini Kilara
1Department of Medical Oncology, M. S. Ramaiah Medical College, Bangalore 560 054, India. drmuralisubramanian@gmail.com
Abstract:
Rituximab is a chimeric anti-CD20 monoclonal antibody used to treat CD20+ non-Hodgkin's lymphoma (NHL). Some pulmonary adverse reactions such as cough, rhinitis, bronchospasm and dyspnea are relatively common. Severe respiratory conditions like cryptogenic organizing pneumonia, interstitial pneumonitis have rarely been reported. We present a case of interstitial pneumonitis in a patient who was treated with R-CHOP for extranodal NHL. He responded to the steroids.
Related Concept Videos
Respiratory Syncytial Virus Disease
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pneumothorax-II
Clinical Manifestations:
Rheumatic Heart Disease I: Introduction